Evaluating the effectiveness of Aspirin in Colorectal Cancer patients in terms of disease free survival and overall survival. - Trial SLCTR_2014_011
Access comprehensive clinical trial information for SLCTR_2014_011 through Pure Global AI's free database. This Phase 3 trial is sponsored by INDOX Cancer Research Network and is currently Recruiting. The study focuses on Colorectal Cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2014_011
Phase 3
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2014_011
Evaluating the effectiveness of Aspirin in Colorectal Cancer patients in terms of disease free survival and overall survival.
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multi-centre, Double Blind, Randomized Placebo Controlled Phase III Trial
Study Focus
Interventional
Sponsor & Location
INDOX Cancer Research Network
China, India, Indonesia, Malaysia, Philippines, Saudi Arabia, Singapore, Sri Lanka, Taiwan
Timeline & Enrollment
Phase 3
Nov 25, 2014
N/A
ICD-10 Classifications
Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2014_011
Non-Device Trial